Avantor, Inc. $AVTR Stake Raised by Fulcrum Asset Management LLP

Fulcrum Asset Management LLP raised its holdings in Avantor, Inc. (NYSE:AVTR) by 2,047.7% in the third quarter, Holdings Channel.com reports. The fund owned 176,112 shares of the company’s stock after acquiring an additional 167,912 shares during the period. Fulcrum Asset Management LLP’s holdings in Avantor were worth $2,684,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. Allspring Global Investments Holdings LLC raised its holdings in shares of Avantor by 7.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 13,253 shares of the company’s stock worth $199,000 after purchasing an additional 957 shares in the last quarter. Ethic Inc. boosted its holdings in Avantor by 158.9% during the third quarter. Ethic Inc. now owns 55,706 shares of the company’s stock worth $838,000 after buying an additional 34,186 shares in the last quarter. Parallel Advisors LLC boosted its holdings in Avantor by 3.8% during the third quarter. Parallel Advisors LLC now owns 19,033 shares of the company’s stock worth $286,000 after buying an additional 693 shares in the last quarter. Chicago Partners Investment Group LLC boosted its holdings in Avantor by 57.8% during the third quarter. Chicago Partners Investment Group LLC now owns 53,137 shares of the company’s stock worth $919,000 after buying an additional 19,455 shares in the last quarter. Finally, True Freedom Investing LLC acquired a new position in Avantor in the third quarter worth approximately $587,000. Institutional investors own 95.08% of the company’s stock.

Avantor Price Performance

AVTR stock opened at $15.59 on Wednesday. The company has a current ratio of 1.89, a quick ratio of 1.27 and a debt-to-equity ratio of 0.63. Avantor, Inc. has a one year low of $7.26 and a one year high of $17.45. The firm has a market capitalization of $10.56 billion, a PE ratio of 19.40, a P/E/G ratio of 7.20 and a beta of 0.95. The firm has a 50-day moving average of $15.64 and a two-hundred day moving average of $11.36.

Avantor (NYSE:AVTR) last released its earnings results on Wednesday, October 28th. The company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.21 by $0.01. The business had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.64 billion. Avantor had a net margin of 5.08% and a return on equity of 9.79%. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period last year, the firm posted $0.22 earnings per share. On average, analysts forecast that Avantor, Inc. will post 0.82 earnings per share for the current year.

Analyst Ratings Changes

Several research firms have issued reports on AVTR. Robert W. Baird upped their price target on Avantor from $17.00 to $18.00 and gave the company an “outperform” rating in a report on Thursday, October 29th. Wells Fargo & Company increased their price objective on Avantor from $14.00 to $16.00 and gave the company an “overweight” rating in a research report on Thursday, July 30th. TD Cowen raised their price objective on Avantor from $15.00 to $17.00 and gave the stock a “hold” rating in a research note on Tuesday, October 13th. Evercore set a $17.00 target price on Avantor in a report on Wednesday, October 28th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $17.00 target price on shares of Avantor in a research report on Thursday, October 29th. Two equities research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Avantor has a consensus rating of “Hold” and an average price target of $14.77.

Avantor Company Profile

Avantor, Inc. is a global provider of products and services used in life sciences, advanced technology and applied materials. Its customers include biopharmaceutical and healthcare companies, laboratories, universities and manufacturers. The company supplies chemicals, reagents, laboratory consumables and equipment, as well as materials used in biopharmaceutical production. Avantor also provides services such as procurement, inventory management and support for laboratory and production operations.